PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
25-Mar-2024 Approval of temporary exemption from certain conditions for maintaining listing pursuant to art. 7 Listing Rules Evolva Holding SA
25-Mar-2024 Approval of temporary exemption from certain conditions for maintaining listing pursuant to art. 7 Listing Rules Evolva Holding SA
25-Mar-2024 NEW UK QUALITATIVE STUDY IDENTIFIES MEN EXPERIENCE BARRIERS TO DIAGNOSIS AND TREATMENT OF TESTOSTERONE DEFICIENCY AT EVERY LEVEL OF THE CARE PATHWAY Besins Healthcare UK
25-Mar-2024 Heidelberg Pharma announces financial figures and reports on successful business performance in 2023 Heidelberg Pharma
25-Mar-2024 Grünenthal reports strong 2023 results with record revenue and continued investments in R&D and acquisitions Grünenthal GmbH
25-Mar-2024 Heidelberg Pharma announces financial figures and reports on successful business performance in 2023 Heidelberg Pharma AG
25-Mar-2024 SYNLAB delivers robust performance in FY 2023 SYNLAB AG
22-Mar-2024 OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101 OKYO Pharma Limited
22-Mar-2024 Cannovum Cannabis AG: Federal Council confirms cannabis legalization as of April 1, 2024, positive growth opportunities in Europe's largest consumer market Cannovum Cannabis AG
22-Mar-2024 MEDICLIN plans to buy Reha-Klinik am Sendesaal MediClin AG
22-Mar-2024 Eckert & Ziegler Continues on Growth Path after Successful Financial Year 2023 Eckert & Ziegler SE
22-Mar-2024 MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act MorphoSys AG
22-Mar-2024 Evolva Holding in liquidation SA publishes liquidation interim financial statements and agenda for 2024 annual general meeting; reports positive purchase price adjustment of CHF 1,929,000 under SPA; g Evolva Holding SA
22-Mar-2024 Biophytis presented its phase 3 protocol in the treatment of sarcopenia Biophytis
22-Mar-2024 Evolva Holding in liquidation SA publishes liquidation interim financial statements and agenda for 2024 annual general meeting; reports positive purchase price adjustment of CHF 1,929,000 under SPA Evolva Holding SA
22-Mar-2024 Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE Relief Therapeutics Holding SA
21-Mar-2024 MEDICLIN invites you to the virtual press conference on the financial statements for the year 2023 MediClin AG
21-Mar-2024 STRATEC PLANS TO DISTRIBUTE DIVIDEND OF € 0.55 PER SHARE FOR 2023 FINANCIAL YEAR STRATEC SE
21-Mar-2024 Eckert & Ziegler Receives MDR Certification for Prostate Seeds, Paving the Way for Long-term Supply Eckert & Ziegler SE
21-Mar-2024 AEVIS VICTORIA SA (AEVS.SW) – Publication of the 2023 revenue AEVIS VICTORIA SA